Supporting clinical trials – discover that industry’s latest trends, news and revenue potentials
What are the prospects for supplying and assisting medical testing? Now you can get revenue forecasts for that market, data helping you stay ahead. Discover financial prospects. And explore pharmaceutical R&D trends, technologies, clients’ needs and opportunities.

This updated report gives you revenue forecasts to 2025 at overall world market, submarket and national level. Examine the high value and potential those pharmaceutical contracting services hold. And there assess technology, results and expected sales.

So what are the secrets of that industry's future success? Please read on to explore clinical trial supply and logistics, also discovering, below, that industry’s potential future revenue.

Forecasting from 2015 and other analysis to help you stay ahead in business information
Besides revenue forecasting to 2025, our new work shows recent results, growth rates and market shares. There you find original analyses. Also investigate healthcare research and development needs. You gain 55 tables, 58 charts and four interviews with companies.

Our new report shows you what the future holds for pharmaceutical contract research organisations (CROs) and manufacturing contractors (CMOs) supplying products and logistics services for clinical trials.

You also explore specialists in logistical support, including cold chain distribution. See, too, progress and implications for drug developers, clinical trial sponsors and organisers.

The purpose of that analysis is to give business predictions that planners, influencers and leaders need. And the following sections explain how that investigation helps you.

Revenues for the clinical trial supply and distribution market and its segments
Along with prediction of the overall world market for those developmental services, our study shows you individual sales predictions for seven submarkets of clinical trial support at world level to 2025:

  • Manufacturing – also with forecasts for packaging and for other production
  • Logistics and distribution – also with forecasts for cold chain logistics and for other services
  • Supply chain management.

Why struggle to find data? Why miss information you need? Instead let our analysis guide you through that healthcare outsourcing industry's present and future, making work easier.

Our report gives you feel for what stimulates and restrains that industry and market. There you identify potential in those technologies and services. See, then, where progress and money lie. Success in business relies on the latest industry knowledge and predictions.

Also find geographical sales projections.

National markets – what outlooks for service demand and provision?
There our analyses show you individual revenue forecasts to 2025 for 11 national markets:

  • The United States (US)
  • Japan
  • EU5 countries – Germany, France, the UK, Italy and Spain
  • BRIC nations – Brazil, Russia, India and China.

For those service providers and clients, many opportunities exist in developed and developing countries. Expanding pharma R&D worldwide will influence that market for outsourced services. Discover in our study how you and your organisation can benefit.

Having that analysis could bring you quicker, easier decisions and results. That way you can benefit in planning and authority on the supply and logistical needs of clinical testing.

There examine the present and future. In particular, our work explains commercial issues.

Developments, challenges and opportunities affecting CROs, CMOs and related companies
The report explains what affects that industry and market from 2015, including these forces:

  • Regulatory standards for clinical trial supply and organisation, inc. good manufacturing practice (GMP) and good distribution practice (GDP)
  • Globalisation – access to new markets and patients, and its effects
  • Supply chain security and other technology for developing and testing medicines
  • Biologics (biological drugs) and other complex therapies
  • Trends in packaging for clinical testing
  • Management of multiple supplier networks.

And also these influences:

  • Cold chain logistics for testing complex drug products, including reusable cold chain packaging and RFID use for temperature monitoring
  • Forecasting and demand modelling to ensure supply
  • IT systems for clinical trial planning: IVRS and IWRS
  • Adaptive clinical trials – how they affect supply and logistical needs
  • Home-based trial participation – challenges and opportunities for that industry.

So you explore strengths, weaknesses, opportunities and threats (SWOT), as well as political, economic, social, and technological questions (STEP), assessing outlooks for that trade.

See there what the future holds.

Organisations leading that pharma outsourcing industry and its overall 2018 revenue
What’s possible for that industry? Our report predicts the world market for that clinical trial support will reach $15.4bn in 2018, with strong expansion from 2015 to 2025.

That work also shows technologies and companies holding greatest potential. In particular, explore activities of these firms, hearing what they’ve achieved and where they head:

  •     Catalent Pharma Solutions
  •     Patheon
  •     Almac Group
  •     Parexel International
  •     Fisher Clinical Services
  •     Movianto

Our study also assesses these service providers, among other organisations:

  •     World Courier
  •     DHL
  •     Marken
  •     TNT Express
  •     FedEx

Also read interviews with four authorities from the industry. Hear what participants think, say and do, helping you stay ahead. So benefit your influence and reputation for insight.

There avoid falling behind. Instead find where progress, potential and money exist, getting information for commercial success.

Ways Clinical Trial Supply and Logistics: World Industry and Market Outlook 2015-2025 helps
In five main ways our new study benefits your research, analysis and knowledge:

  • See revenues possible from 2015 to 2025 in that overall world market and 7 submarkets, as well as 11 top national markets in the Americas, Europe and Asia.
  • Explore regulations and their effects in regional and national markets in 2014, also assessing trends and prospects from 2015.
  • Examine service and drug development issues affecting that outsourcing market’s participants and their clients from 2015, also getting SWOT and STEP analyses.
  • Assess prospects for established, emerging and rising service providers, exploring portfolios, results, deals, technologies and progress.
  • Gather insight on the present and future from authorities on clinical trial supply and logistics, including opinion from our survey’s four interviews with prominent firms.

However knowledgeable you are, benefit now from our forecasting, discussions and interviewing. Those methods our analysts have refined and extended for more than 10 years, providing healthcare analyses to explain opportunities and potential revenues.

That way stay ahead, getting predictions top companies depend on again and again.

Potentials for clinical trial supplying and distributing – discover from 2015 what’s possible
In our new report you receive competitive intelligence found only in that work, seeing where money, progress and opportunities exist, now and in future.

That way you’re less likely to miss opportunity or fall behind. Instead stay ahead for commercial and technological knowledge. There explore trends, progress and revenue predications. So please get that new investigation here now.